🔥🐔 BizChicken 🐔🔥
Companies Similar to PTC Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Allarity Therapeutics, Inc.
Stenoparib, Dovitinib, IXEMPRA, Li Pla Cis, 2X-111
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing oncology therapeutics using companion diagnostics and drug response predictor technology.
Careers | Careers | Careers | About | About | About | About | About | About | About | About | Contact | Contact | Contact | Careers | About | About | About | About | About | About | About | About
Symbol: ALLR
Recent Price: $1.12
Industry: Biotechnology
CEO: Mr. Thomas H. Jensen
Sector: Healthcare
Employees: 5
Address: 210 Broadway, Cambridge, MA 02139
Phone: 401 426 4664
Last updated: 2024-12-31
Protagonist Therapeutics, Inc.
rusfertide (PTG-300), PN-943, PN-235
Protagonist Therapeutics, Inc. is a biopharmaceutical company that focuses on the discovery and development of peptide-based therapeutic drugs for hematology, blood disorders, and inflammatory and immunomodulatory diseases.
Symbol: PTGX
Recent Price: $38.51
Industry: Biotechnology
CEO: Dr. Dinesh V. Patel Ph.D.
Sector: Healthcare
Employees: 125
Address: 7707 Gateway Boulevard, Newark, CA 94560-1160
Phone: 510 474 0170
Last updated: 2024-12-31
Sarepta Therapeutics, Inc.
EXONDYS 51, VYONDYS 53, AMONDYS 45, SRP-5051, SRP-9001, SRP-9003
Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on developing RNA-targeted therapeutics and gene therapies for rare diseases, including treatments for Duchenne muscular dystrophy.
Contact | About | Leadership | About | About | About | Locations | About | About | About | About
Symbol: SRPT
Recent Price: $121.19
Industry: Biotechnology
CEO: Mr. Douglas S. Ingram Esq.
Sector: Healthcare
Employees: 1314
Address: 215 First Street, Cambridge, MA 02142
Phone: 617 274 4000
Leadership
- Douglas S. Ingram, President and Chief Executive Officer
- Bilal Arif, Executive Vice President, Chief Technical Operations Officer
- Diane Berry, PhD, Executive Vice President, Chief Global Policy & Advocacy Officer
- Ryan E. Brown, JD, Executive Vice President, Chief General Counsel
- Ian M. Estepan, Executive Vice President, Chief Financial Officer
- Dallan Murray, Executive Vice President, Chief Customer Officer
- Alison Nasisi, Executive Vice President, Chief People Officer
- Louise R. Rodino-Klapac, PhD, Executive Vice President, Head of R&D, Chief Scientific Officer
- Will Tilton, Senior Vice President, Head of Strategy, Chief of Staff
- M. Kathleen Behrens, PhD, Chairwoman
- Richard J. Barry,
- Kathryn Boor, PhD,
- Michael Chambers,
- Deirdre Connelly,
- Stephen L. Mayo, PhD,
- Claude Nicaise, MD,
- Hans Wigzell, MD, PhD,
- John C. Martin, PhD (In Memoriam),
- Annemieke Aartsma-Rus, PhD,
- Carsten Bönnemann, MD,
- Joy Cavagnaro, PhD, DABT, Fellow ATS,
- Kay Davies, PhD, DBE FMedSci FRS,
- Steven Gray, PhD,
- Angela J. Russell, DPhil,
Last updated: 2024-12-31
Tenaya Therapeutics, Inc.
TN-201, TN-301, TN-401
Tenaya Therapeutics, Inc. is a biotechnology company that discovers, develops, and delivers therapies for heart disease using cellular regeneration, gene therapy, and precision medicine platforms.
Symbol: TNYA
Recent Price: $1.45
Industry: Biotechnology
CEO: Mr. Faraz Ali M.B.A.
Sector: Healthcare
Employees: 140
Address: 171 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 825 6900
Last updated: 2024-12-31
Travere Therapeutics, Inc.
Chenodal, Cholbam, Thiola, Sparsentan, TVT-058
Travere Therapeutics, Inc. is a biopharmaceutical company that focuses on identifying, developing, commercializing, and delivering therapies for the treatment of rare diseases. Its products include Chenodal, Cholbam, Thiola, and candidates like Sparsentan and TVT-058.
About | Leadership | About | About | About | Contact | Contact | Careers | Careers | About | News | About | About | About | About | About | About | News | Events | About | About | ESG | About | Jobs | Jobs | Careers | About | About | About | About
Symbol: TVTX
Recent Price: $17.32
Industry: Biotechnology
CEO: Dr. Eric M. Dube Ph.D.
Sector: Healthcare
Employees: 380
Address: 3611 Valley Centre Drive, San Diego, CA 92130
Phone: 888 969 7879
Leadership
- Eric Dube, Ph.D., President & Chief Executive Officer
- Chris Cline, CFA, Chief Financial Officer
- Angela Giannantonio, Senior Vice President, Human Resources
- Peter Heerma, Chief Commercial Officer
- Jula Inrig, M.D., Chief Medical Officer
- Casey Logan, Chief Business Officer
- Elizabeth Reed, J.D., Senior Vice President, General Counsel, Corporate Secretary
- William Rote, Ph.D., Senior Vice President, Research & Development
- Charlotte Smith, Senior Vice President, Public Affairs
- Gary A. Lyons, Chairman
- Roy D. Baynes, M.D., Ph.D.,
- Suzanne L. Bruhn, Ph.D.,
- Tim Coughlin, CPA,
- Jeffrey A. Meckler,
- John A. Orwin,
- Sandra E. Poole,
- Ron Squarer,
- Ruth Williams-Brinkley, FACHE,
Last updated: 2024-12-31
Eloxx Pharmaceuticals, Inc.
ELX-02
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing ribosome modulation therapies for rare and ultra-rare premature stop codon diseases. The company's lead investigational drug, ELX-02, is in Phase 2 clinical trials for cystic fibrosis and nephropathic cystinosis.
Symbol: ELOX
Recent Price: $0.00
Industry: Biotechnology
CEO: Mr. Sumit Aggarwal M.B.A.
Sector: Healthcare
Employees: 18
Address: 480 Arsenal Way, Watertown, MA 02472
Phone: 781 577 5300
Last updated: 2024-12-31
Ligand Pharmaceuticals Incorporated
Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.
Symbol: LGND
Recent Price: $105.76
Industry: Biotechnology
CEO: Mr. Todd C. Davis Ph.D.
Sector: Healthcare
Employees: 58
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 858 550 7500
Last updated: 2024-12-31
PTC Therapeutics, Inc.
Translarna, Emflaza, Tegsedi, Waylivra, Evrysdi
PTC Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for patients with rare disorders. The company offers a portfolio of products including treatments for Duchenne muscular dystrophy, rare diseases, and spinal muscular atrophy.
About | History | Leadership | About | Contact | Careers | Careers | Jobs | About | About | About | About
Symbol: PTCT
Recent Price: $45.77
Industry: Biotechnology
CEO: Dr. Matthew B. Klein F.A.C.S., M.D., M.S.
Sector: Healthcare
Employees: 988
Address: 100 Corporate Court, South Plainfield, NJ 07080
Phone: 908 222 7000
Leadership
- Matthew B. Klein, M.D., M.S., F.A.C.S., CEO, PTC Therapeutics, Inc.
- Neil Almstead, Ph.D., Chief Technical Operations Officer
- John Baird, Ph.D., Chief of Staff to the CEO
- Mark E. Boulding, Executive Vice President and Chief Legal Officer
- Lee Golden, M.D., Chief Medical Officer
- Pierre Gravier, Chief Financial Officer
- Mary Frances Harmon, Senior Vice President, Corporate and Patient Relations
- Linda Montella-Carter, Senior Vice President and Chief Information Officer
- Eric Pauwels, Chief Business Officer
- Hege Sollie-Zetlmayer, Chief Human Resources Officer
- Christine Utter, Senior Vice President, Chief Accounting Officer and Head of People Services
- Michael Schmertzler, Chairman
- William F. Bell, Jr., Managing Director and Head of Healthcare Services Practice, L.E.K. Consulting
- Allan Jacobson, Ph.D., University of Massachusetts Chan Medical School
- Stephanie S. Okey, M.S., Former SVP, Head of North America, Rare Disease – Genzyme
- Emma Reeve, Independent Board Director
- Mary Smith, The VENG Group
- David P. Southwell, Former CEO, TScan Therapeutics
- Glenn D. Steele, Jr., M.D., Ph.D., Chairman, GSteele Health Solutions
- Alethia Young, Chief Financial Officer, Bicycle Therapeutics
- Jerome B. Zeldis, M.D., Ph.D., Independent Board Director
Last updated: 2024-12-31
Protagenic Therapeutics, Inc.
PT00114
Protagenic Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing therapeutics for stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, aims to regulate stress response and restore healthy brain function.
Symbol: PTIX
Recent Price: $0.54
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 1
Address: 149 Fifth Avenue, New York, NY 10010
Phone: 212 994 8200
Last updated: 2024-12-31
Ultragenyx Pharmaceutical Inc.
Crysvita, Mepsevii, Dojolvi, Evkeeza, DTX401, DTX301
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on the development and commercialization of products for rare and ultra-rare genetic diseases worldwide.
Leadership | About | About | About
Symbol: RARE
Recent Price: $42.27
Industry: Biotechnology
CEO: Dr. Emil D. Kakkis M.D., Ph.D.
Sector: Healthcare
Employees: 1276
Address: 60 Leveroni Court, Novato, CA 94949
Phone: 415 483 8800
Last updated: 2024-12-31
Rocket Pharmaceuticals, Inc.
Gene Therapies
Rocket Pharmaceuticals, Inc. is a biotechnology company focused on developing gene therapies for rare and devastating diseases, with multiple clinical-stage programs targeting disorders such as fanconi anemia, leukocyte adhesion deficiency-I, pyruvate kinase deficiency, and Danon disease.
Symbol: RCKT
Recent Price: $12.03
Industry: Biotechnology
CEO: Dr. Gaurav D. Shah M.D.
Sector: Healthcare
Employees: 268
Address: 9 Cedarbrook Drive, Cranbury, NJ 08512
Phone: 609 659 8001
Last updated: 2024-12-31
Relay Therapeutics, Inc.
RLY-4008, RLY-2608, RLY-1971
Relay Therapeutics, Inc. is a clinical-stage company that focuses on precision medicine in oncology and genetic diseases by transforming the drug discovery process. Their leading products include small molecule inhibitors for advanced cancer treatment.
Symbol: RLAY
Recent Price: $4.18
Industry: Biotechnology
CEO: Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS
Sector: Healthcare
Employees: 323
Address: 399 Binney Street, Cambridge, MA 02139
Phone: 617 370 8837
Last updated: 2024-12-31
TransCode Therapeutics, Inc.
TTX-MC138
Trans Code Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing drugs and diagnostics for treating metastatic disease. Their lead product, TTX-MC138, is aimed at metastatic cancer treatment, along with a range of other therapeutic platforms targeting cancer through innovative RNA- and CRISPR-based technologies.
Symbol: RNAZ
Recent Price: $3.76
Industry: Biotechnology
CEO: Mr. Thomas A. Fitzgerald M.B.A.
Sector: Healthcare
Employees: 10
Address: 6 Liberty Square, Boston, MA 02109
Phone: 857-837-3099
Last updated: 2024-12-31
Protara Therapeutics, Inc.
N/A
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.
No tags available.
Symbol: TARA
Recent Price: $5.28
Industry: Biotechnology
CEO: Mr. Jesse Shefferman
Sector: Healthcare
Employees: 26
Address: 345 Park Avenue South, New York, NY 10010
Phone: 646 844 0337
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31
vTv Therapeutics Inc.
TTP399
v Tv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing orally administered treatments for diabetes and other diseases. Key products include TTP399 for type 1 diabetes and HPP737 for inflammatory diseases.
Symbol: VTVT
Recent Price: $13.97
Industry: Biotechnology
CEO: Mr. Paul J. Sekhri M.Sc.
Sector: Healthcare
Employees: 16
Address: 3980 Premier Drive, High Point, NC 27265
Phone: 336 841 0300
Last updated: 2024-12-31
Zevra Therapeutics, Inc.
KP1077, KP879
Zevra Therapeutics is a rare disease company focused on developing proprietary prodrugs using Ligand Activated Therapy to treat medical conditions such as ADHD, stimulant use disorder, and CNS rare diseases. Their lead candidates include KP1077 for idiopathic hypersomnia and KP879 for stimulant use disorder.
About | Contact | Careers | Careers | About | About | About | About | About | About | About | About | Leadership | Directors | About | Careers | Contact | Vision/Values | About
Symbol: ZVRA
Recent Price: $8.21
Industry: Biotechnology
CEO: Mr. Neil F. McFarlane
Sector: Healthcare
Employees: 65
Address: 1180 Celebration Boulevard, Celebration, FL 34747
Phone: 321 939 3416
Last updated: 2024-12-31
Cadrenal Therapeutics, Inc. Common Stock
Tecarfarin
Cadrenal Therapeutics, Inc. is a clinical development biopharmaceutical company focusing on novel therapies for preventing systemic thromboembolism in patients with specific health conditions, headquartered in Ponte Vedra, Florida.
Symbol: CVKD
Recent Price: $14.23
Industry: Biotechnology
CEO: Mr. Quang X. Pham
Sector: Healthcare
Employees: 4
Address: 822 A1A North, Ponte Vedra, FL 32082
Phone: 904 300 0701
Last updated: 2024-12-31
Ionis Pharmaceuticals, Inc.
RNA-targeted therapeutics
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States, offering treatments like SPINRAZA, TEGSEDI, and WAYLIVRA, while developing medicines in phase 3 studies for various indications including TTR amyloidosis, severe hypertriglyceridemia, and amyotrophic lateral sclerosis.
About | About | About | DEI | DEI | DEI | DEI | Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | About | About | News | About | About | ESG | DEI | DEI | About | About | About | Management | About | About | About | About | About | About | About | About | About | About | Careers | Careers | Careers | Careers | Careers | ESG | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About | About | About | Jobs | About | About
Symbol: IONS
Recent Price: $34.92
Industry: Biotechnology
CEO: Dr. Brett P. Monia Ph.D.
Sector: Healthcare
Employees: 927
Address: 2855 Gazelle Court, Carlsbad, CA 92010
Phone: 760 931 9200
Last updated: 2024-12-31
Larimar Therapeutics, Inc.
CTI-1601
Larimar Therapeutics, Inc. is a clinical-stage biotechnology company developing treatments for rare diseases using a novel cell penetrating peptide technology platform. Their lead product candidate, CTI-1601, is undergoing Phase 1 clinical trials to treat Friedreich's ataxia.
About | Leadership | Directors | About | Contact | Contact | Careers | Careers | About | About | About | Careers
Symbol: LRMR
Recent Price: $3.91
Industry: Biotechnology
CEO: Dr. Carole S. Ben-Maimon M.D.
Sector: Healthcare
Employees: 42
Address: Three Bala Plaza East, Bala Cynwyd, PA 19004
Phone: 844 511 9056
Leadership
- Carole Ben-Maimon, MD, President and Chief Executive Officer
- Gopi Shankar, PhD, MBA, FAAPS, Chief Development Officer
- Rusty Clayton, DO, Chief Medical Officer
- Michael Celano, CHIEF FINANCIAL OFFICER
- John Berman, Vice President of Finance and Administration
- Jennifer Johansson, Vice President, Legal and Compliance
- Keith E. Lynch, Jr., Vice President, CMC Technical Operations
- Noreen Scherer, Vice President of Clinical Operations
- Francis Michael Conway, CPA, VICE PRESIDENT AND CONTROLLER
- Mohamed Hamdani, Vice President, Statistics and Quantitative Sciences
- Adrienne Clements-Egan, Ph.D., Vice President, Bioanalytics and Developability
- Frank Nazzario, RPh, Vice President, Commercial
- Joseph Truitt, BOARD CHAIR
- Tom Hamilton,
- Jonathan Leff,
- Frank E. Thomas,
- Jeffrey Sherman, MD,
- ,
Last updated: 2024-12-31